Drawing for BIOCELLIC

USPTO serial 79414765

BIOCELLIC

Reviewed by CopyMark Law Group

Reg. 8226581Status 700Registered
Filing date
Status date
Registration date
Apr 28, 2026
Examiner
SWAIN, MICHELE LYNN
Law office
Historical data usage

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIOCELLIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph V. Norvell

PO Box 2461Chicago, IL 60690United States

Goods and services

ClassDescriptionStatusFirst use
001Cellulose precursors and cellulose intermediates for cosmetical, pharmaceutical, medical and veterinary-medical end products; cellulose for use as raw material for wound dressings; cellulose made by bacteria; cellulose for industrial purposes; cellulose gel; nanocellulose; unprocessed cellulose fleece, cellulose foil, cellulose films and cellulose fibres; cellulose fibres suspensions and cellulose gels of nanocellulose; cellulose and nanocellulose products, namely, biosynthetic cellulose and synthetic cellulose as precursors for veterinary, and cosmetical products, particularly for wound dressings; cellulose ingredients for use in the cosmetic and medical industries; cellulose and nanocellulose products, namely, biosynthetic cellulose and synthetic cellulose as precursors for pharmaceutical products; cellulose-based ingredients for use in manufacturing cosmetics industry and the medical device industry; cellulose-based ingredients as support material, thickening and binding agents for use in manufacturing cosmetics and medical products, particularly wound dressings and skin care preparations; cellulose for the food industry; cellulose derivatives for use manufacturing; diagnostic preparations and substances for scientific purposes; diagnostic testing materials for scientific use; none of the above-mentioned goods being products to be taken orally; none of the above-mentioned goods being products containing collagenACTIVE—
003Cosmetics and cosmetic preparations; cosmetic-based cellulose fleece, cellulose foils, cellulose films, cellulose fibres, cellulose fibre suspensions and cellulose gels impregnated with cosmetic active ingredients, particularly skin care preparations; beauty masks; skin masks; facial masks; body masks, skin care preparations; none of the above-mentioned goods being products to be taken orally; none of the above-mentioned goods being products containing collagen.ACTIVE—
005Medical and veterinary preparations, namely, cellulose products, namely, biosynthetic cellulose and synthetic cellulose for skin treatment; flat cellulose, namely, cellulose films, cellulose foils, cellulose fleece, cellulose fibres, cellulose fibre suspension and cellulose gels for medical, veterinary and pharmaceutical purposes; pharmaceutical preparations featuring cellulose fleece, cellulose films, cellulose foils, cellulose fibres, cellulose fibre suspensions and cellulose gels for use in the treatment of skin; pharmaceutical preparations featuring cellulose fleece, cellulose films, cellulose foils, cellulose fibres, cellulose fibre suspension and cellulose gels impregnated with pharmaceutical agents for use in the treatment of skin; pads impregnated with medicated preparation for use in the treatment of skin for medical purposes; cellulose for pharmaceutical, veterinary and medical purposes; pharmaceutical preparations for skin care; absorbent sanitary pads for skin treatment; pantyliners; diapers; sanitary pads; preparations for the treatment of burns, except ready-to-use wound dressings; diagnostic preparations for pharmaceutical, medical and veterinary purposes.ACTIVE—
017Semi-finished products, namely, synthetic resins * of cellulose, cellulose fleece, cellulose films, cellulose foils, cellulose fibres, cellulose fibre suspension and cellulose gels * for making materials for dressing wounds and surgical dressings; semi-finished products, namely, acrylics made of cellulose, cellulose fleece, cellulose films, cellulose foils, cellulose fibres, cellulose fibre suspension and cellulose gels for making material for dressings and surgical dressings; semi-finished molded products of cellulose fleece, cellulose films, cellulose foils, cellulose fibres, cellulose fibre suspension and cellulose gels for use as semi-finished products for making absorbent sanitary articles, pantyliners, diapers and sanitary pads; semi-processed cellulose fleece, cellulose foil, cellulose films and cellulose fibres for use in food and beveragesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 5, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 27, 2026NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Oct 16, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 16, 2026FIMPFINAL DISPOSITION PROCESSED—
Oct 16, 2026LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Oct 7, 2026COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Oct 7, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 28, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 2, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 15, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 15, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 28, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 28, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 10, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 10, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 17, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 22, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 22, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 16, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 21, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 21, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2025LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jul 5, 2025RFNTREFUSAL PROCESSED BY IB—
Jun 13, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 13, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 29, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 28, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2025DOCKASSIGNED TO EXAMINER—
Jan 16, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 16, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 16, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance